SCHEMBL18833152

SCHEMBL18833152

CCCCOc1cc2[nH]c(-c3n[nH]cc3NC(=O)N3CCCC3)nc2cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.38
ITK Q08881 1/20 0.38
PDE5A O76074 1/20 0.38
KMT2A Q03164 2/20 0.37
CYP3A4 P08684 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAPT P10636 2/20 0.33
GCK P35557 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
P2RY12 Q9H244 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
HTT P42858 1/20 0.33
FGFR1 P11362 1/20 0.33
FLT1 P17948 1/20 0.33
CHEK2 O96017 1/20 0.32
STS P08842 1/20 0.32
EGLN1 Q9GZT9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13373931 0.91 SYK (0.45) SYKITKPDE5AKMT2ACYP3A4
SCHEMBL3926980 0.91 SYK (0.37) SYKITKPDE5AKMT2ACYP3A4
SCHEMBL3928004 0.90 SYK (0.36) SYKITKPDE5AKMT2ACYP3A4
SCHEMBL3926346 0.89 CHEK2 (0.41) SYKITKKMT2AFGFR1FLT1
Hydrochloric Acid SCHEMBL4126862 0.88 CHEK2 (0.40) SYKITKKMT2AFGFR1FLT1
Trifluoroacetic Acid SCHEMBL4145377 0.86 SYK (0.34) SYKITKPDE5AKMT2ACYP3A4
SCHEMBL3924905 0.86 CHEK2 (0.39) SYKITKPDE5AKMT2ACYP3A4
SCHEMBL3923205 0.85 HRH4 (0.37) SYKITKMAPTHRH4PDE3B
SCHEMBL5952616 0.85 SYK (0.44) SYKITKHSD17B10MAPTTP53
SCHEMBL3926161 0.85 SYK (0.36) SYKITKHSD17B10MAPTHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2041119-B1 PYRAZOLYLBENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND USE THEREOF AVENTIS PHARMA SA (FR) 2017-05-10 EP disclosed